In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...

Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical ...